CIK 0000315545
- Non-accelerated filer
- Smaller reporting company
PROVECTUS BIOPHARMACEUTICALS, INC.
Sign in to watch- Ticker
- PVCT
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 900031917
- Phone
- +1 866-594-5999
- Business address
- 800 S. GAY STREET, SUITE 1610, KNOXVILLE, TN, 37929
- Former names
- PROVECTUS PHARMACEUTICALS INC, PROVECTUS PHARMACEUTICAL INC, ZAMAGE DIGITAL IMAGING INC, SPM GROUP INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-06-20 | Horowitz Bruce COO | Option exercise · 8% Secured Convertible Promissory Notes due 2021 | −0 | 0 | ||
| 2021-06-20 | Horowitz Bruce COO | Option exercise · Series D-1 Convertible Preferred Stock | +38,473 | 38,473 | ||
| 2021-06-17 | Raines Heather CFO | Grant or award · 8% Secured Convertible Promissory Notes due 2021 | +0 | |||
| 2021-06-17 | Bailey Webster Director | Grant or award · 8% Secured Convertible Promissory Notes due 2021 | +0 | |||
| 2021-06-17 | Pershing Edward Director | Grant or award · 8% Secured Convertible Promissory Notes due 2021 | +0 | |||
| 2021-06-17 | WACHTER ERIC PHD CTO | Grant or award · 8% Secured Convertible Promissory Notes due 2021 | +0 | |||
| 2021-06-17 | Horowitz Bruce COO | Grant or award · 8% Secured Convertible Promissory Notes due 2021 | +0 | |||
| 2020-11-10 | Raines Heather CFO | Grant or award | +50,000 | 1,213,153 | ||
| 2020-11-10 | Lacy John III Director | Grant or award | +100,000 | 200,000 | ||
| 2020-11-10 | Lacy John III Director | Grant or award · Stock Options (Right to Buy) | +100,000 | 100,000 | ||
| 2020-11-10 | Horowitz Bruce Chief Operating Officer | Grant or award | +800,000 | 2,227,243 | ||
| 2020-11-10 | Horowitz Bruce Chief Operating Officer | Grant or award · Stock Options (Right to Buy) | +2,425,000 | 2,425,000 | ||
| 2019-03-25 | Raines Heather Chief Financial Officer | Grant or award | +50,000 | 1,163,153 | ||
| 2017-12-14 | Glass John R See Remarks | Purchase | +84,100 | $0.05 | $5K | 84,100 |
| 2017-12-14 | Glass John R See Remarks | Purchase | +115,900 | $0.05 | $6K | 200,000 |
| 2016-03-29 | CULPEPPER PETER R Interim CEO, CFO, COO | Other acquisition | +133,333 | $1.00 | $133K | 1,384,496 |
| 2016-03-29 | CULPEPPER PETER R Interim CEO, CFO, COO | Other acquisition | +27,333 | $1.00 | $27K | 1,411,829 |
| 2016-03-29 | CULPEPPER PETER R Interim CEO, CFO, COO | Other acquisition | +106,000 | $1.00 | $106K | 296,503 |
| 2016-03-29 | CULPEPPER PETER R Interim CEO, CFO, COO | Other disposition · Common Stock Warrants (right to buy) | −133,333 | 0 | ||
| 2016-03-29 | CULPEPPER PETER R Interim CEO, CFO, COO | Other acquisition · Common Stock Warrants (right to buy) | +133,333 | 133,333 |
Page 13 of 17 · 329 trades